Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00482989 · ClinicalTrials.gov registry record · Phase 1

A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus

A Phase 1 study of Lupus, sponsored by MedImmune.

Completed
Registry status
Phase 1
Development phase
183
Enrollment target
20
Study locations

NCT00482989 is a Phase 1 study of Lupus that has completed, run by MedImmune. The registered enrollment target is 183 participants, below the 271-participant average among 13 other Lupus trials with a reported enrollment target (32% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00482989, a Phase 1 study of Lupus, has completed, sponsored by MedImmune.

COMPLETED
Registry status
Phase 1
Development phase
183 participants
Enrollment target
20
Study locations

Study Summary

To evaluate the safety and tolerability of multiple IV doses of the MEDIMUNNE antibody in adult patients with SLE.

Conditions Studied

Lupus

Interventions

  • OTHER Placebo
  • BIOLOGICAL MEDI 545

Study Locations (20)

Florida

  • Research Site - Clearwater
  • Research Site - Fort Lauderdale
  • Research Site - Ocala
  • Research Site - Tampa

New York

  • Research Site - Manhasset
  • Research Site - New York
  • Research Site - New York

California

  • Research Site - La Jolla
  • Research Site - Los Angeles

Maryland

  • Research Site - Baltimore
  • Research Site - Bethesda

Texas

  • Research Site - Dallas
  • Research Site - Dallas

Other

  • Research Site - Buenos Aires
  • Research Site - San Miguel de Tucumán

Alabama

  • Research Site - Anniston

Louisiana

  • Research Site - Shreveport

Trial Details

FieldValue
Enrollment Target 183 participants
Start Date 2007-06
Est. Completion 2010-09
Phase Phase 1

Sponsor

MedImmune

210 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00482989

The ClinicalTrials.gov registry entry for NCT00482989 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 271-participant average among 13 other Lupus trials with a reported enrollment target (32% lower). The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lupus appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00482989 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, New York, California.

Frequently Asked Questions

What is clinical trial NCT00482989 about?

NCT00482989 is a clinical study titled "A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus". To evaluate the safety and tolerability of multiple IV doses of the MEDIMUNNE antibody in adult patients with SLE.

What is the current status of trial NCT00482989?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 183 participants. The study started on 2007-06. Estimated completion is 2010-09.

What conditions does trial NCT00482989 study?

This clinical trial studies the following conditions: Lupus.

What interventions are being tested in trial NCT00482989?

The interventions under investigation include: Placebo (OTHER), MEDI 545 (BIOLOGICAL).

Who is sponsoring clinical trial NCT00482989?

This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00482989 being conducted?

This trial has 20 study locations across Alabama, California, Florida, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lupus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lupus

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.